⌘K

Home/Filings/4/0000899243-23-006468

4//SEC Filing

Bachleda Mark 4

Accession 0000899243-23-006468

CIK 0001563577other

View on SEC.gov Company Profile

Filed

Feb 27, 7:00 PM ET

Accepted

Feb 28, 6:56 PM ET

Size

5.4 KB

Accession

0000899243-23-006468

Insider Transaction Report

Form 4

Period: 2023-02-25

Galera Therapeutics, Inc.GRTX

Chief Commercial Officer

Transactions

Award
Stock Option (Right to Buy)
2023-02-25+135,000→ 135,000 total
Exercise: $1.78Exp: 2033-02-24→ Common Stock (135,000 underlying)

Footnotes (1)

[F1]The option vests and becomes exercisable in 48 substantially equal monthly installments with the first installment vesting on March 25, 2023.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Galera Therapeutics, Inc.

CIK 0001563577

Entity typeother

Related Parties

1

filerCIK 0001887762

Filing Metadata

Form type: 4
Filed: Feb 27, 7:00 PM ET
Accepted: Feb 28, 6:56 PM ET
Size: 5.4 KB

View on SEC.gov